Pluma, Jayson .

HRN: 21-60-92  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/03/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
07/03/2024
07/09/2024
IVTT
2.25 G
Q6
Infected Wound,sepsis, Renal Dose
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: